ClinicalTrials.gg
RecruitingNCT05023005Updated Apr 24, 2026

Strain-Counterstrain Treatment of Piriformis Pain

An interventional study of Strain-Counterstrain treatment of piriformis muscle in Low Back Pain, Mechanical, Piriformis Syndrome and Somatic Dysfunction of Sacral Region (Finding), sponsored by Loma Linda University. Recruiting at 1 site in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-24.

Sponsored by Loma Linda University · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 712 studies in Low Back Pain with a site in United States — 100 open to participants now, 126 under way, 3 of them phase 3. Low Back Pain · United States.

Planned enrollment
480th of 623
30 · median 79
Started
2026
with 32 others
No phase
408 of 712
62 open now
Primary completion
2027-09
later than 76 of 125 live
Registered
540th of 712
by date

Among the 712 studies in Low Back Pain with a site in United States, this one is the 480th largest by planned enrollment of the 623 interventional ones that give a count, is one of 33 that started in 2026, is one of 408 with no phase, reaches primary completion later than 76 of the 125 other live ones, and was the 540th registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

100 of the 712 studies in Low Back Pain with a site in United States are open now. Recruiting first, the newest first:

94 more — sign in →

All 100 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 712 studies in Low Back Pain with a site in United States, or all of them as a file.
02

Study summary

The purpose of this investigator-initiated study is to provide an efficient and non-invasive treatment option for pain caused by the piriformis muscle.

Read the detailed description

There are two arms to the study: treatment and sham. The treatment group will receive strain-counterstrain for the piriformis muscle. The sham group will receive strain-counterstrain treatment for the hamstring muscle.

There will be two treatments, 1-2 weeks apart ideally.

Participants will fill out the Oswestry Disability Index Questionnaire before the first treatment and after the second treatment (which is 1-2 weeks after the first treatment).

Participants will also identify pain using the Visual Analog Scale (VAS) before and after each treatment. Participants will identify pain at rest prior to treatment using VAS. Participant will then identify pain at the start of treatment while pressure is applied to the piriformis muscle (4.5kg/cm2) and post treatment while pressure is applied to the piriformis muscle (4.5 kg/cm2).

An algometer will be used pre and post each treatment (2 treatments that are 1-2 weeks apart) to objectively measure any change in pain pressure threshold.

03

Conditions studied

  • Low Back Pain, Mechanical
  • Piriformis Syndrome
  • Somatic Dysfunction of Sacral Region (Finding)
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18 to 65 years of age
  • Tender point (or trigger point) in piriformis muscle determined by physical exam

Exclusion criteria

Exclusion criteria:

  • Less than 45 degrees of active hip flexion, less than 5 degrees of active hip internal rotation or less than 30 degrees of active hip external rotation, on side of affected piriformis
  • Unable to lay prone
  • Non-English speaker
  • Inability to attend 2 sessions within the same month
  • Active cancer
  • Pregnant
  • Diagnosis of lumbar radiculopathy
  • Greater than grade 1 lumbar spondylolisthesis
  • Presence of lumbar region Pars Defect
  • Receiving massage, acupuncture, chiropractic treatments, osteopathic treatments during study period.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Piriformis Strain-Counterstrain

    The treatment group will receive strain-counterstrain for the piriformis muscle.

    Other: Strain-Counterstrain treatment of piriformis muscle

  • Sham comparator
    Hamstring Strain-Counterstrain

    The sham group will receive strain-counterstrain treatment for the hamstring muscle.

    Other: Strain-Counterstrain treatment of piriformis muscle

Interventions

  • OtherStrain-Counterstrain treatment of piriformis muscle

    Participant will lay prone on table with affected leg close to edge of table. Piriformis muscle tender point is identified and palpated. Then patient leg is passively moved off table and passive hip flexion, abduction, and possible internal/external rotation is added to reduce tender point by 70% or more. This is done passively. This position is held for 90 seconds and then participant is passively returned back to neutral prone position with leg on table. Tender point is palpated again to reassess for change in pain (using subjective visual analog scale). An algometer is also used pre and post to assess objective change in pressure pain threshold.

06

What researchers measure

Primary outcomes

  1. Algometer - Change in pressure pain threshold

    Objective improvement in pressure/pain threshold

    Time frame: Pre and post each treatment. There are 2 treatments, 1-2 weeks apart from one another.

Secondary outcomes

  1. Change in Visual Analog Scale

    Subjective improvement in low back/leg pain

    Time frame: Pre and post each treatment. There are 2 treatments, 1-2 weeks apart from one another.

  2. Change in Oswestry Disability Index

    Assesses pain with doing different activities (sleeping, walking, sitting, etc), assesses ability to do activities of daily living

    Time frame: Before first treatment and after second treatment. Each treatment is 1-2 weeks apart (anticipated).

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for Sep 2027, 12 months later.

Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's planned 12 months is close to that.

Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 11, 2021
First posted
Aug 26, 2021
StartEst.
Sep 2026
Primary completionEst.
Sep 2027
CompletionEst.
Sep 2027
Last update
Apr 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05023005
Responsible party
Sponsor
First posted
Aug 26, 2021
Start date
Sep 2026 (estimated)
Primary completion
Sep 2027 (estimated)
Completion
Sep 2027 (estimated)
Last update
Apr 24, 2026

Study contacts

Roya Vahdatinia, DO
Contact
rvahdatinia@llu.edu
9095586202
Mickey Lui, DO
Contact
Mickey.Lui@va.gov
9095586202
Mickey Lui
principal investigator · Loma Linda University Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion